Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Kazuteru Noguchi, Tetsuya Furukawa, Yoshiki Tatsumi, Shuhei Kasama, Takahiro Yoshikawa, Teppei Hashimoto, Naoto Azuma, Seiichi Hirota, Takashi Kimura & Kiyoshi Matsui. (2024) Involvement of YKL-40-positive macrophages commonly identified in polymyositis and dermatomyositis in the pathogenesis of myositis: a retrospective study. Immunological Medicine 47:1, pages 37-44.
Read now
Read now
Natalia Przysucha, Katarzyna Górska & Rafal Krenke. (2020) Chitinases and Chitinase-Like Proteins in Obstructive Lung Diseases – Current Concepts and Potential Applications. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 885-899.
Read now
Read now
Tetsuya Furukawa, Kiyoshi Matsui, Masayasu Kitano, Yuichi Yokoyama, Masahiro Sekiguchi, Naoto Azuma, Yasutomo Imai, Seiichi Hirota, Kiyofumi Yamanishi & Hajime Sano. (2019) Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. Modern Rheumatology 29:3, pages 476-483.
Read now
Read now
Maureen C. Turina, Robert Landewé & Dominique Baeten. (2017) Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA. Expert Review of Clinical Immunology 13:4, pages 333-344.
Read now
Read now
Abdullah Tuten, Mine Kucur, Metehan Imamoglu, Mahmut Oncul, Abdullah Serdar Acikgoz, Nigar Sofiyeva, Zeynep Ozturk, Baris Kaya & Engin Oral. (2014) Serum YKL-40 levels are altered in endometriosis. Gynecological Endocrinology 30:5, pages 381-384.
Read now
Read now
Anders B. Mathiasen, Marina J. Harutyunyan, Erik Jørgensen, Steffen Helqvist, Rasmus Ripa, Jens P. Gøtze, Julia S. Johansen & Jens Kastrup. (2011) Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 71:5, pages 439-447.
Read now
Read now
Anders Bruun Mathiasen, Kristoffer Mads Aaris Henningsen, Marina Jurjevna Harutyunyan, Naja Dam Mygind & Jens Kastrup. (2010) YKL-40: A New Biomarker in Cardiovascular Disease?. Biomarkers in Medicine 4:4, pages 591-600.
Read now
Read now
M. Kazakova, T. Deneva, V. Uzunova & V. Sarafian. (2010) YKL-40 in Healthy Subjects. Biotechnology & Biotechnological Equipment 24:sup1, pages 125-128.
Read now
Read now
Julia S Johansen, Nicolai A Schultz & Benny V Jensen. (2009) Plasma YKL-40: A Potential New Cancer Biomarker?. Future Oncology 5:7, pages 1065-1082.
Read now
Read now
Yongzhong Wang, Rasmus Sejersten Ripa, Julia Sidenius Johansen, Anders Gabrielsen, Daniel A. Steinbrüchel, Tina Friis, Lene Bindslev, Mandana Haack-Sørensen, Erik Jørgensen & Jens Kastrup. (2008) YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scandinavian Cardiovascular Journal 42:5, pages 295-302.
Read now
Read now
Frederick D. Coffman. (2008) Chitinase 3-Like-1 (CHI3L1): A Putative Disease Marker at the Interface of Proteomics and Glycomics. Critical Reviews in Clinical Laboratory Sciences 45:6, pages 531-562.
Read now
Read now
Julia S Johansen, Benny Vittrup Jensen, Anne Roslind & Paul A Price. (2007) Is YKL-40 a new therapeutic target in cancer?. Expert Opinion on Therapeutic Targets 11:2, pages 219-234.
Read now
Read now
Articles from other publishers (102)
Emiko Mizoguchi, Takayuki Sadanaga, Linda Nanni, Siyuan Wang & Atsushi Mizoguchi. (2024) Recently Updated Role of Chitinase 3-like 1 on Various Cell Types as a Major Influencer of Chronic Inflammation. Cells 13:8, pages 678.
Crossref
Crossref
Shu-Hong Bi, Chunyan Su, La-Ta A, Yue Wang, Lian He & Ai-Hua Zhang. (2024) YKL-40 (chitinase-3-like protein 1) serum levels are associated with abdominal aortic calcification in hemodialysis patients. International Urology and Nephrology.
Crossref
Crossref
Dejan Bakula, Nikolina Vrkljan, Valentina Ratkajec, Goran Glavcic, Marijana Miler, Stipe Pelajic, Dunja Rogic, Nina Blazevic, Tajana Pavic & Davor Hrabar. (2024) YKL-40 as a biomarker in various inflammatory diseases. Biochemia medica 34:1.
Crossref
Crossref
Nora Sipeki, Patricia Julianna Kovats, Claudia Deutschmann, Peter Schierack, Dirk Roggenbuck & Maria Papp. (2023) Location-based prediction model for Crohn’s disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies. World Journal of Gastroenterology 29:42, pages 5728-5750.
Crossref
Crossref
Angela Maria Di Francesco, Elena Verrecchia, Stefano Manna, Andrea Urbani & Raffaele Manna. (2023) The chitinases as biomarkers in immune-mediate diseases. Clinical Chemistry and Laboratory Medicine (CCLM) 61:8, pages 1363-1381.
Crossref
Crossref
Helena Tavares de Sousa & Fernando Magro. (2023) How to Evaluate Fibrosis in IBD?. Diagnostics 13:13, pages 2188.
Crossref
Crossref
Kazuaki Okawa, Eri Tabata, Yuta Kida, Kyohei Uno, Hidetoshi Suzuki, Minori Kamaya, Peter O. Bauer & Fumitaka Oyama. (2023)
Irreversible evolutionary loss of chitin‐degrading ability in the chitinase‐like protein
Y
m1 under positive selection in rodents
. Protein Science 32:4.
Crossref
Crossref
Susanne N. Wijesinghe, Amel Badoume, Dominika E. Nanus, Archana Sharma‐Oates, Hussein Farah, Michelangelo Certo, Fawzeyah Alnajjar, Edward T. Davis, Claudio Mauro, Mark A. Lindsay & Simon W. Jones. (2023) Obesity defined molecular endotypes in the synovium of patients with osteoarthritis provides a rationale for therapeutic targeting of fibroblast subsets. Clinical and Translational Medicine 13:4.
Crossref
Crossref
Maha Alhelf, Laila Rashed, Sahar Ahmed, Mohamed Mohamed & Marwa Abdelgwad. (2022) Can Micro RNA-24 Affect the Cardiovascular Morbidity in Systemic Lupus Erythematosus by Targeting YKL-40?. Reports of Biochemistry and Molecular Biology 11:3, pages 511-523.
Crossref
Crossref
Adriaan G. Volkers, Laura Appleton, Richard B. Gearry, Christopher M. Frampton, Floris A. E. de Voogd, Annemieke M. Peters van Ton, Steven T. Leach, Daniel A. Lemberg & Andrew S. Day. (2022) Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease. Gastrointestinal Disorders 4:3, pages 180-189.
Crossref
Crossref
Yu Lu, Na Chang, Xinhao Zhao, Renmin Xue, Jing Liu, Lin Yang & Liying Li. (2022) Activated Neutrophils Secrete Chitinase-Like 1 and Attenuate Liver Inflammation by Inhibiting Pro-Inflammatory Macrophage Responses. Frontiers in Immunology 13.
Crossref
Crossref
Alina Jankowska-Konsur, Magdalena Łyko, Klaudia Rubas, Danuta Nowicka-Suszko, Joanna Maj & Jacek C. Szepietowski. (2022) Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum. Acta Dermato-Venereologica 102, pages adv00646.
Crossref
Crossref
YUI TERATANI. (2021) Chitinase 3-Like-1 Expression Is Upregulated Under Inflammatory Conditions in Human Oral Epithelial Cells. The Kurume Medical Journal 68:3.4, pages 221-228.
Crossref
Crossref
Sung Soo Ahn, Taejun Yoon, Yong-Beom Park, Maria Prendecki, Gurjeet Bhangal, Stephen P. McAdoo & Sang-Won Lee. (2021) Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Marzena Mazur, Anna Zielińska, Marcin M. Grzybowski, Jacek Olczak & Jakub Fichna. (2021) Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases. International Journal of Molecular Sciences 22:13, pages 6966.
Crossref
Crossref
Riccardo Mager, Giulia Roda, Mohammad Khaled Shalaby & Stefania Vetrano. (2021) Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors. Current Drug Targets 22:2, pages 241-251.
Crossref
Crossref
Emiko Mizoguchi, Renuka Subramaniam, Toshiyuki Okada & Atsushi Mizoguchi. (2021) A Review of Selected IBD Biomarkers: From Animal Models to Bedside. Diagnostics 11:2, pages 207.
Crossref
Crossref
Yuan Qi, Li-Sha Chou, Lin-Jie Zhang, Ming-Qi Liu, Ming Yi, Qiu-Xia Zhang, Jing Wang, Ting Li, Da-Qi Zhang & Li Yang. (2020) Increased cerebrospinal fluid YKL-40 levels are associated with disease severity of neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders 45, pages 102395.
Crossref
Crossref
Yoowon Kwon, Ju Hee Kim, Eun Kyo Ha, Hye Mi Jee, Hey Sung Baek, Man Yong Han & Su Jin Jeong. (2020) Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children. Mediators of Inflammation 2020, pages 1-7.
Crossref
Crossref
Jin Shen He, Jin Yu Tan, Xiao Zhi Li, Rui Feng, Shan Shan Xiong, Si Nan Lin, Yun Qiu & Ren Mao. (2020) Serum biomarkers of fibrostenotic Crohn's disease: Where are we now?. Journal of Digestive Diseases 21:6, pages 336-341.
Crossref
Crossref
Andrea P. Thorn, Mette L. Harving, Gunnar S. Lausten, Julia S. Johansen, Michala S. Sørensen & Michael M. Petersen. (2020) Plasma YKL-40 as a biomarker in patients with nonmetastatic bone and soft tissue sarcomas: a prospective exploratory clinical study. International Journal of Surgery Oncology 5:3.
Crossref
Crossref
Magali de Bruyn, Randy Ringold, Erik Martens, Marc Ferrante, Gert Van Assche, Ghislain Opdenakker, Avinoam Dukler & Séverine Vermeire. (2020) The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor. Journal of Crohn's and Colitis 14:2, pages 176-184.
Crossref
Crossref
Anna Szymańska-Chabowska, Jan Juzwiszyn, Beata Jankowska-Polańska, Wojciech Tański & Mariusz Chabowski. 2020. Health and Medicine. Health and Medicine
1
8
.
Mariangela Allocca, Gionata Fiorino, Cristiana Bonifacio, Laurent Peyrin-Biroulet & Silvio Danese. (2019) Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology 17:12, pages 2397-2415.
Crossref
Crossref
Fikriye MİLLETLİ SEZGİN & Rukiye NAR. (2019) Determination of serum YKL-40 levels in patients with brucellosisBruselloz hastalarında serum YKL-40 düzeylerinin belirlenmesi. Turkish Journal of Clinics and Laboratory 10:3, pages 335-339.
Crossref
Crossref
Rashid Nadeem, Mahwish Nida, Shafaq Jawed & Basil Nasrallah. (2019) Elevation in Circulating YKL-40 Levels in Patients with Stroke: A Review and Meta-Analysis. Dubai Medical Journal 2:2, pages 59-66.
Crossref
Crossref
Claudia Deutschmann, Mandy Sowa, Jayaseelan Murugaiyan, Uwe Roesler, Nadja Röber, Karsten Conrad, Martin W Laass, Dimitrios Bogdanos, Nora Sipeki, Maria Papp, Stefan Rödiger, Dirk Roggenbuck & Peter Schierack. (2019) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn’s Disease. Journal of Crohn's and Colitis 13:7, pages 894-904.
Crossref
Crossref
Anu Paul, Manuel Comabella & Roopali Gandhi. (2019) Biomarkers in Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 9:3, pages a029058.
Crossref
Crossref
Sally Ziatabar, Jennifer Zepf, Sushama Rich, Ben T. Danielson, Paul I. Bollyky & Robert Stern. (2018) Chitin, chitinases, and chitin lectins: Emerging roles in human pathophysiology. Pathophysiology 25:4, pages 253-262.
Crossref
Crossref
Amal Ahmed Abd El-Fattah, Nermin Abdel Hamid Sadik, Olfat Gamil Shaker & Amal Mohamed Kamal. (2018) Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk. Mediators of Inflammation 2018, pages 1-23.
Crossref
Crossref
Shan Xing, Xin Zheng, Tao Zeng, Mu-Sheng Zeng, Qian Zhong, Yue-Song Cao, Kai-Lu Pan, Chu Wei, Fan Hou & Wan-Li Liu. (2017) Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World Journal of Gastroenterology 23:43, pages 7693-7704.
Crossref
Crossref
Gilles Duvoisin, Robert N. Lopez, Andrew S. Day, Daniel A. Lemberg, Richard B. Gearry & Steven T. Leach. (2017) Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation 2017, pages 1-9.
Crossref
Crossref
Manuela Capone, Laura Maggi, Veronica Santarlasci, Maria Caterina Rossi, Alessio Mazzoni, Gianni Montaini, Rolando Cimaz, Matteo Ramazzotti, Marie Pierre Piccinni, Giusi Barra, Raffaele De Palma, Francesco Liotta, Enrico Maggi, Sergio Romagnani, Francesco Annunziato & Lorenzo Cosmi. (2016) Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients. Clinical and Molecular Allergy 14:1.
Crossref
Crossref
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino & Axel U. Dignass. (2016) European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 10:8, pages 873-885.
Crossref
Crossref
Amal Ahmed Abd El-Fattah, Nermin Abdel Hamid Sadik, Olfat Gamil Shaker & Amal Mohamed Kamal. (2016) Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?. Tumor Biology 37:7, pages 9387-9397.
Crossref
Crossref
Pierre-Paul Axisa & David A. Hafler. (2016) Multiple sclerosis. Current Opinion in Neurology 29:3, pages 345-353.
Crossref
Crossref
Stephanie J. Bissel, Julia Kofler, Julia Nyaundi, Michael Murphey-Corb, Stephen R. Wisniewski & Clayton A. Wiley. (2016) Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis. Journal of Neuroimmune Pharmacology 11:2, pages 332-347.
Crossref
Crossref
Michelino Di Rosa, Gisella Distefano, Katarzyna Zorena & Lucia Malaguarnera. (2016) Chitinases and immunity: Ancestral molecules with new functions. Immunobiology 221:3, pages 399-411.
Crossref
Crossref
Michelino Di Rosa, Violetta Maria Brundo & Lucia Malaguarnera. (2016) New insights on chitinases immunologic activities. World Journal of Immunology 6:2, pages 96.
Crossref
Crossref
Chun-Jung Huang, Aaron L Slusher, Michael Whitehurst, Marie Wells, Arun Maharaj & Yoshimi Shibata. (2015) The impact of acute aerobic exercise on chitinase 3-like protein 1 and intelectin-1 expression in obesity. Experimental Biology and Medicine 241:2, pages 216-221.
Crossref
Crossref
Michelino Di Rosa & Lucia Malaguarnera. (2016) Chitinase 3 Like-1: An Emerging Molecule Involved in Diabetes and Diabetic Complications. Pathobiology 83:5, pages 228-242.
Crossref
Crossref
Stefan Bohr, Suraj J. Patel, Radovan Vasko, Keyue Shen, Alexander Golberg, Francois Berthiaume & Martin L. Yarmush. (2015) The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model. PLOS ONE 10:11, pages e0140440.
Crossref
Crossref
William J. Housley, David Pitt & David A. Hafler. (2015) Biomarkers in multiple sclerosis. Clinical Immunology 161:1, pages 51-58.
Crossref
Crossref
Ester Cantó, Carmen Espejo, Carme Costa, Xavier Montalban & Manuel Comabella. (2015) Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction. Clinical Immunology 160:2, pages 133-141.
Crossref
Crossref
Weiwei Jiang & Xuhang Li. (2015) Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 19:3, pages 141-158.
Crossref
Crossref
Misa Ohno, Peter Bauer, Yuta Kida, Masayoshi Sakaguchi, Yasusato Sugahara & Fumitaka Oyama. (2015) Quantitative Real-Time PCR Analysis of YKL-40 and Its Comparison with Mammalian Chitinase mRNAs in Normal Human Tissues Using a Single Standard DNA. International Journal of Molecular Sciences 16:12, pages 9922-9935.
Crossref
Crossref
Ester Cantó, Mar Tintoré, Luisa M. Villar, Carme Costa, Ramil Nurtdinov, José C. Álvarez-Cermeño, Georgina Arrambide, Ferran Reverter, Florian Deisenhammer, Harald Hegen, Mohsen Khademi, Tomas Olsson, Hayrettin Tumani, Eulalia Rodríguez-Martín, Fredrik Piehl, Ales Bartos, Denisa Zimova, Jolana Kotoucova, Jens Kuhle, Ludwig Kappos, Juan Antonio García-Merino, Antonio José Sánchez, Albert Saiz, Yolanda Blanco, Rogier Hintzen, Naghmeh Jafari, David Brassat, Florian Lauda, Romy Roesler, Konrad Rejdak, Ewa Papuc, Clara de Andrés, Stefan Rauch, Michael Khalil, Christian Enzinger, Daniela Galimberti, Elio Scarpini, Charlotte Teunissen, Alex Sánchez, Alex Rovira, Xavier Montalban & Manuel Comabella. (2015) Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. Brain 138:4, pages 918-931.
Crossref
Crossref
Xin Zheng, Shan Xing, Xiao-Min Liu, Wen Liu, Dan Liu, Pei-Dong Chi, Hao Chen, Shu-Qin Dai, Qian Zhong, Mu-Sheng Zeng & Wan-Li Liu. (2014) Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer 14:1.
Crossref
Crossref
Misa Ohno, Yuta Kida, Masayoshi Sakaguchi, Yasusato Sugahara & Fumitaka Oyama. (2014) Establishment of a quantitative PCR system for discriminating chitinase-like proteins: catalytically inactive breast regression protein-39 and Ym1 are constitutive genes in mouse lung. BMC Molecular Biology 15:1.
Crossref
Crossref
Tara E Sutherland, Nicola Logan, Dominik Rückerl, Alison A Humbles, Stuart M Allan, Venizelos Papayannopoulos, Brigitta Stockinger, Rick M Maizels & Judith E Allen. (2014) Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage. Nature Immunology 15:12, pages 1116-1125.
Crossref
Crossref
Carah B. Santos, Joshua Davidson, Ronina A. Covar & Joseph D. Spahn. (2014) The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children. Annals of Allergy, Asthma & Immunology 113:3, pages 263-266.
Crossref
Crossref
Chun-Jung Huang, Kathleen N. Beasley, Edmund O. Acevedo, Robert L. Franco, Tamekia L. Jones, David C. Mari & Yoshimi Shibata. (2014) Chitin enhances obese inflammation ex vivo. Human Immunology 75:1, pages 41-46.
Crossref
Crossref
Stephania Libreros, Ramon Garcia-Areas & Vijaya Iragavarapu-Charyulu. (2013) CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors. Immunologic Research 57:1-3, pages 99-105.
Crossref
Crossref
Brian Kornblit, Dorthe Hellemann, Lea Munthe-Fog, Jan Bonde, Jens J. Strøm, Hans O. Madsen, Julia S. Johansen & Peter Garred. (2013) Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis—Experience from two prospective cohorts. Immunobiology 218:10, pages 1227-1234.
Crossref
Crossref
P. Jensen, C. Wiell, K. Milting, R.P. Poggenborg, M. Østergaard, J.S. Johansen & L. Skov. (2012) Plasma YKL‐40: a potential biomarker for psoriatic arthritis?. Journal of the European Academy of Dermatology and Venereology 27:7, pages 815-819.
Crossref
Crossref
Mansi Prakash, Manish Bodas, Divya Prakash, Neelu Nawani, Madhukar Khetmalas, Abul Mandal & Cecilia Eriksson. (2013) Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling. Cellular Signalling 25:7, pages 1567-1573.
Crossref
Crossref
Gülay Ulusal Okyay, Ramazan Erdem Er, Merve Yasemin Tekbudak, Özge Paşaoğlu, Salih İnal, Kürşad Öneç, Hatice Paşaoğlu, Kadriye Altok, Ülver Derici & Yasemin Erten. (2012) Novel Inflammatory Marker in Dialysis Patients: YKL‐40. Therapeutic Apheresis and Dialysis 17:2, pages 193-201.
Crossref
Crossref
F. Zorzi, E. Calabrese, I. Monteleone, M. Fantini, S. Onali, L. Biancone, F. Pallone & G. Monteleone. (2012)
A phase 1 open‐label trial shows that smad7 antisense oligonucleotide (
GED
0301) does not increase the risk of small bowel strictures in Crohn's disease
. Alimentary Pharmacology & Therapeutics 36:9, pages 850-857.
Crossref
Crossref
Chun Geun Lee, Charles S. Dela Cruz, Bing Ma, Farida Ahangari, Yang Zhou, Ruth Halaban, Mario Sznol & Jack A. Elias. (2012) Chitinase-like Proteins in Lung Injury, Repair, and Metastasis. Proceedings of the American Thoracic Society 9:2, pages 57-61.
Crossref
Crossref
Jens Kastrup. (2012) Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?. Immunobiology 217:5, pages 483-491.
Crossref
Crossref
G. S. GuptaRajesh K. Gupta & G. S. Gupta. 2012. Animal Lectins: Form, Function and Clinical Applications. Animal Lectins: Form, Function and Clinical Applications
421
437
.
T. Aomatsu, H. Imaeda, K. Matsumoto, E. Kimura, A. Yoden, H. Tamai, Y. Fujiyama, E. Mizoguchi & A. Andoh. (2011) Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 34:8, pages 941-948.
Crossref
Crossref
Paweł Stawerski, Małgorzata Wągrowska-Danilewicz, Olga Stasikowska-Kanicka & Marian Danilewicz. (2011) Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers. Pathology - Research and Practice 207:9, pages 573-576.
Crossref
Crossref
Chun-Chuan Chen, Victoria Llado, Katrin Eurich, Hoa T. Tran & Emiko Mizoguchi. (2011) Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clinical Immunology 140:3, pages 268-275.
Crossref
Crossref
Anne Mette Mørup, Brian Kornblit, Julia S. Johansen, Tania Nicole Masmas, Hans O. Madsen, Lars Vindeløv & Peter Garred. (2011) The Prognostic Value of YKL-40 Concentrations in Nonmyeloablative Conditioning Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 17:9, pages 1299-1307.
Crossref
Crossref
Chun-Chuan Chen, Joel Pekow, Victoria Llado, Manasa Kanneganti, Cindy W. Lau, Atsushi Mizoguchi, Mari Mino-Kenudson, Marc Bissonnette & Emiko Mizoguchi. (2011) Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia. The American Journal of Pathology 179:3, pages 1494-1503.
Crossref
Crossref
Anders R. Nielsen, Peter Plomgaard, Karen S. Krabbe, Julia S. Johansen & Bente K. Pedersen. (2011) IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine 55:1, pages 152-155.
Crossref
Crossref
Jorge CorrealeMarcela Fiol. (2010) Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Multiple Sclerosis Journal 17:5, pages 521-531.
Crossref
Crossref
Chun Geun LeeCarla A. Da SilvaCharles S. Dela CruzFarida AhangariBing MaMin-Jong KangChuan-Hua HeSeyedtaghi Takyar & Jack A. Elias. (2011) Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury. Annual Review of Physiology 73:1, pages 479-501.
Crossref
Crossref
Manasa Kanneganti, Mari Mino-Kenudson & Emiko Mizoguchi. (2011) Animal Models of Colitis-Associated Carcinogenesis. Journal of Biomedicine and Biotechnology 2011, pages 1-23.
Crossref
Crossref
L. Zou, X. He & J.W. Zhang. (2010) The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Brazilian Journal of Medical and Biological Research 43:12, pages 1232-1238.
Crossref
Crossref
Annika E. Michelsen, Camilla N. Rathcke, Mona Skjelland, Sverre Holm, Trine Ranheim, Kirsten Krohg-Sørensen, Marit F. Klingvall, Frank Brosstad, Erik Øie, Henrik Vestergaard, Pål Aukrust & Bente Halvorsen. (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:2, pages 589-595.
Crossref
Crossref
Nicolai A. Schultz & Julia S. Johansen. (2010) YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?. Cancers 2:3, pages 1453-1491.
Crossref
Crossref
Jian Lei Zheng, Lin Lu, Jian Hu, Rui Yan Zhang, Qi Zhang, Qiu Jin Chen & Wei Feng Shen. (2010) Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Atherosclerosis 210:2, pages 590-595.
Crossref
Crossref
Kristoffer Mads Henningsen, Brian Nilsson, Julia S. Johansen, Xu Chen, Steen Pehrson & Jesper Hastrup Svendsen. (2009) Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation. Inflammation Research 59:6, pages 463-469.
Crossref
Crossref
Kazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, Tetsuhiko Yoshida, Hidetoshi Takahashi, Naomi Iike, Masao Iwase, Kouzin Kamino, Ryouhei Ishii, Hiroaki Kazui, Motoyuki Fukumoto, Hironori Takamura, Hidenaga Yamamori, Michiyo Azechi, Koji Ikezawa, Hitoshi Tanimukai, Shinji Tagami, Takashi Morihara, Masayasu Okochi, Kazuo Yamada, Shusuke Numata, Masashi Ikeda, Toshihisa Tanaka, Takashi Kudo, Shu-ichi Ueno, Takeo Yoshikawa, Tetsuro Ohmori, Nakao Iwata, Norio Ozaki & Masatoshi Takeda. (2010) The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case–control study and meta-analysis. Schizophrenia Research 116:2-3, pages 126-132.
Crossref
Crossref
T. E. Sutherland, R. M. Maizels & J. E. Allen. (2009) Chitinases and chitinase‐like proteins: potential therapeutic targets for the treatment of T‐helper type 2 allergies. Clinical & Experimental Allergy 39:7, pages 943-955.
Crossref
Crossref
Katrin Eurich, Mayuko Segawa, Satoko Toei-Shimizu & Emiko Mizoguchi. (2009) Potential role of chitinase 3-like-1 in inflammationassociated carcinogenic changes of epithelial cells. World Journal of Gastroenterology 15:42, pages 5249.
Crossref
Crossref
Elisabetta Dal Pont, Renata D’Incà, Antonino Caruso & Giacomo Carlo Sturniolo. (2009) Non-invasive investigation in patients with inflammatory joint disease. World Journal of Gastroenterology 15:20, pages 2463.
Crossref
Crossref
Hyun-Joo Seol, Eun-Sung Lee, So-Eun Jung, Nan-Hee Jeong, Ji-Eun Lim, Sung-Hoon Park, Soon-Cheol Hong, Min-Jeong Oh & Hai-Joong Kim. (2009) Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in patients with preeclampsia. Journal of Reproductive Immunology 79:2, pages 183-187.
Crossref
Crossref
Anne Roslind & Julia S. Johansen. 2009. Inflammation and Cancer. Inflammation and Cancer
159
184
.
Annika Berntsen, Redas Trepiakas, Lynn Wenandy, Poul F. Geertsen, Per thor Straten, Mads H. Andersen, Anders E. Pedersen, Mogens H. Claesson, Torben Lorentzen, Julia S. Johansen & Inge Marie Svane. (2008) Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma. Journal of Immunotherapy 31:8, pages 771-780.
Crossref
Crossref
Yusuf Erzin, Hafize Uzun, Adem Karatas & Aykut Ferhat Celik. (2008) Serum YKL‐40 as a marker of disease activity and stricture formation in patients with Crohn's disease. Journal of Gastroenterology and Hepatology 23:8pt2.
Crossref
Crossref
Camilla Nøjgaard, Nis B. Høst, Ib Jarle Christensen, Steen Hvitfeldt Poulsen, Kenneth Egstrup, Paul A. Price & Julia S. Johansen. (2008) Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coronary Artery Disease 19:4, pages 257-263.
Crossref
Crossref
Anne E. Torrence, Thea Brabb, Joanne L. Viney, Helle Bielefeldt-Ohmann, Piper Treuting, Audrey Seamons, Rolf Drivdahl, Weiping Zeng & Lillian Maggio-Price. (2008) Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. Inflammatory Bowel Diseases 14:4, pages 480-490.
Crossref
Crossref
J S Johansen, A N Pedersen, M Schroll, T Jørgensen, B K Pedersen & H Bruunsgaard. (2008) High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clinical and Experimental Immunology 151:2, pages 260-266.
Crossref
Crossref
Mine Kucur, Ferruh K. Isman, Bilgehan Karadag, Vural A. Vural & Sedat Tavsanoglu. (2007) Serum YKL-40 levels in patients with coronary artery disease. Coronary Artery Disease 18:5, pages 391-396.
Crossref
Crossref
Merete Ringsholt, Estrid V. S. Høgdall, Julia S. Johansen, Paul A. Price & Lise H. Christensen. (2007) YKL-40 protein expression in normal adult human tissues – an immunohistochemical study. Journal of Molecular Histology 38:1, pages 33-43.
Crossref
Crossref
Mayumi Kawada, Yuriko Hachiya, Atsuko Arihiro & Emiko Mizoguchi. (2007) Role of mammalian chitinases in inflammatory conditions. The Keio Journal of Medicine 56:1, pages 21-27.
Crossref
Crossref
Emiko Mizoguchi & Atsushi Mizoguchi. (2007) Is the sugar always sweet in intestinal inflammation?. Immunologic Research 37:1, pages 47-60.
Crossref
Crossref
Anne K. Mylin, Thomas Rasmussen, Julia S. Johansen, Lene M. Knudsen, Peter H. Nørgaard, Stig Lenhoff, Inger M. S. Dahl & Hans E. Johnsen. (2006) Serum YKL‐40 concentrations in newly diagnosed multiple myeloma patients and YKL‐40 expression in malignant plasma cells. European Journal of Haematology 77:5, pages 416-424.
Crossref
Crossref
Adília Hormigo, Bin Gu, Sasan Karimi, Elyn Riedel, Katherine S. Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti S. Rao, Martin Fleisher, Lisa M. DeAngelis & Eric C. Holland. (2006) YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas. Clinical Cancer Research 12:19, pages 5698-5704.
Crossref
Crossref
Julia Kzhyshkowska, A. Gratchev & S. Goerdt. (2006) Stabilin-1, a homeostatic scavenger receptor with multiple functions. Journal of Cellular and Molecular Medicine 10:3, pages 635-649.
Crossref
Crossref
Julia KzhyshkowskaSrinivas MamidiAlexei GratchevElisabeth KremmerChristina SchmuttermaierLiis KrusellGeorg HausJochen UtikalKai SchledzewskiJoachim ScholtzeSergij Goerdt. (2006) Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107:8, pages 3221-3228.
Crossref
Crossref
Henrik Schmidt, Julia Sidenius Johansen, Julie Gehl, Poul F. Geertsen, Kirsten Fode & Hans von der Maase. (2006) Elevated serum level of YKL‐40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer 106:5, pages 1130-1139.
Crossref
Crossref
Julia S. Johansen, Benny Vittrup Jensen, Anne Roslind, Dorte Nielsen & Paul A. Price. (2006) Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?. Cancer Epidemiology, Biomarkers & Prevention 15:2, pages 194-202.
Crossref
Crossref
Olav J. Bergmann, Julia S. Johansen, Tobias W. Klausen, Anne K. Mylin, Jørgen S. Kristensen, Eigil Kjeldsen & Hans E. Johnsen. (2005) High Serum Concentration of YKL-40 Is Associated with Short Survival in Patients with Acute Myeloid Leukemia. Clinical Cancer Research 11:24, pages 8644-8652.
Crossref
Crossref
Christopher E. Pelloski, Anita Mahajan, Moshe Maor, Eric L. Chang, Shiao Woo, Mark Gilbert, Howard Colman, Helen Yang, Alicia Ledoux, Hilary Blair, Sandra Passe, Robert B. Jenkins & Kenneth D. Aldape. (2005) YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma. Clinical Cancer Research 11:9, pages 3326-3334.
Crossref
Crossref
Nanna Junker, Julia S. Johansen, Claus B. Andersen & Paul E.G. Kristjansen. (2005) Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer 48:2, pages 223-231.
Crossref
Crossref
Julia S. Johansen, Nils Milman, Michael Hansen, Charly Garbarsch, Paul A. Price & Niels Graudal. (2005) Increased serum YKL-40 in patients with pulmonary sarcoidosis—a potential marker of disease activity?. Respiratory Medicine 99:4, pages 396-402.
Crossref
Crossref
Catherine L. Nutt, Rebecca A. Betensky, Melissa A. Brower, Tracy T. Batchelor, David N. Louis & Anat O. Stemmer-Rachamimov. (2005) YKL-40 Is a Differential Diagnostic Marker for Histologic Subtypes of High-Grade Gliomas. Clinical Cancer Research 11:6, pages 2258-2264.
Crossref
Crossref
Nanna Junker, Julia S. Johansen, Lasse T. Hansen, Eva L. Lund & Paul E.G. Kristjansen. (2005) Regulation of YKL‐40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Science 96:3, pages 183-190.
Crossref
Crossref